Coronavirus update: Biden announces changes to vaccine rollout
Yahoo Finance · 14h ago
Vaccines versus variants: Israel's exit from pandemic hangs in balance · 14h ago
Biden’s Vaccine-Supply Drive Falls Short of Surging Demand
The Biden administration’s move to boost the supply of Covid-19 vaccines in coming weeks amounts to opening the faucet a little wider: Even with the extra flow, demand for the shots will still swamp supply for months unless the U.S. can open another spigot...
Bloomberg · 14h ago
UPDATE 1-Spanish regions cap COVID-19 vaccinations due to slowing supply · 14h ago
Merck's (MRK) Keytruda Gets EC Nod for MSI-H Colorectal Cancer
The European Commission approves Merck's (MRK) Keytruda as a monotherapy for first-line treatment of patients with metastatic MSI-H or dMMR colorectal cancer.
Zacks · 15h ago
Pfizer (PFE) to Report Q4 Earnings: What's in the Cards?
Zacks · 15h ago
Scientists Still Relentlessly Working to Develop Newest, More Advanced Antiviral Therapies for COVID-19 Treatments
, /PRNewswire/ -- The antivirals market consists of sales of antiviral drugs and related services. Antiviral drugs reduce the replication of viruses at different stages. Various type of viral infections for which antiviral drugs are used include HIV, herp...
PR Newswire - PRF · 15h ago
Moderna: U.S. gov plans to order an additional 100 million doses of its COVID-19 vaccine
Shares of Moderna Inc. undefined were down 2.1% in premarket trading on Wednesday after the company said it was in talks with the U.S. government to supply...
MarketWatch · 15h ago
Czech ministry recommends two-week halt of first-dose COVID-19 vaccinations- CTK agency · 16h ago
Government to order 200M more COVID-19 vaccine doses
The U.S. government is ordering 200M more COVID-19 vaccine doses, President Joe Biden said Tuesday.The order to be fulfilled over the summer will include extra 100M doses of Pfizer (PFE) /BioNTech
Seekingalpha · 16h ago
Stocks making the biggest moves in the premarket: Boeing, AT&T, VF Corp., Starbucks & more
The stocks making the biggest moves in premarket trading include Boeing, AT&T, VF Corp., Starbucks, and more. · 16h ago
Governments Are Scrambling for Vaccine Doses. More Supplies Seem Imminent. · 16h ago
UK police dealing with incident at plant producing AstraZeneca vaccines · 16h ago
Salesforce unveils Vaccine Cloud to manage COVID-19 records · 16h ago
UPDATE 1-South Africa approves AstraZeneca vaccine for emergency use · 16h ago
Regeneron says its COVID-19 antibody cocktail still works against new strains in lab test
Shares of Regeneron Pharmaceuticals Inc. undefined gained 1.2% in premarket trading on Wednesday after the company said its COVID-19 antibody cocktail still...
MarketWatch · 16h ago
The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 26)
Benzinga · 16h ago
Pfizer's Xeljanz fails to meet co-primary endpoint in rheumatoid arthritis study
Pfizer (PFE) announces co-primary endpoint results a safety study, ORAL Surveillance. The primary objective of this study was to evaluate the safety of Xeljanz (tofacitinib) at two doses (5 and
Seekingalpha · 16h ago
Regeneron antibody cocktail works against UK and South African variants, study finds
Regeneron has released research on the company's coronavirus antibody cocktail that found the cocktail retains its potency against the U.K. and South African variants of the virus. The study was done in conjunction with Columbia University researcher Dr. D... · 17h ago
5 things to know before the stock market opens Wednesday
U.S. stock futures were lower, with earnings once again a main focus on Wall Street. · 17h ago
Webull provides a variety of real-time PFE stock news. You can receive the latest news about Pfizer through multiple platforms. This information may help you make smarter investment decisions.
About PFE
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.